Abstract:Abstract Rapid plasmonic biosensing has attracted wide attention in early disease diagnosis and molecular biology research. However, it was still challenging for conventional angle-interrogating plasmonic sensors to obtain higher sensitivity without secondary amplifying labels such as plasmonic nanoparticles. To address this issue, we developed a plasmonic biosensor based on the enhanced lateral position shift by phase singularity. Such singularity presents as a sudden phase retardation at the dark point of reflection from resonating plasmonic substrate, leading to a giant position shift on reflected beam. Herein, for the first time, the atomically thin layer of Ge 2 Sb 2 Te 5 (GST) on silver nanofilm was demonstrated as a novel phase-response-enhancing plasmonic material. The GST layer was not only precisely engineered to singularize phase change but also served as a protective layer for active silver nanofilm. This new configuration has achieved a record-breaking largest position shift of 439.3 μm measured in calibration experiments with an ultra-high sensitivity of 1.72 × 10 8 nm RIU −1 (refractive index unit). The detection limit was determined to be 6.97 × 10 −7 RIU with a 0.12 μm position resolution. Besides, a large figure of merit (FOM) of 4.54 × 10 11 μm (RIU∙°) −1 was evaluated for such position shift interrogation, enabling the labelfree detection of trace amounts of biomolecules. In targeted biosensing experiments, the optimized sensor has successfully detected small cytokine biomarkers (TNF-α and IL-6) with the lowest concentration of 1 × 10 −16 M. These two molecules are the key proinflammatory cancer markers in clinical diagnosis, which cannot be directly screened by current clinical techniques. To further validate the selectivity of our sensing systems, we also measured the affinity of integrin binding to arginylglycylaspartic acid (RGD) peptide (a key protein interaction in cell adhesion) with different Mn 2+ ion concentrations, ranging from 1 nM to 1 mM.

Hot Spot-Localized Artificial Antibodies for Label-Free Plasmonic Biosensing.

Plasmonic Nano-Arrays for Ultrasensitive Bio-Sensing

Nanoplasmonic Biosensor Using Localized Surface Plasmon Resonance Spectroscopy for Biochemical Detection.

A Plasmonic Nanosensor for Immunoassay Via Enzyme-Triggered Click Chemistry

Trapping Proteins Within Gold Nanoparticle Assemblies: Dynamically Tunable Hot-Spots for Nanobiosensing

Gold Nanocages with Built-In Artificial Antibodies for Label-Free Plasmonic Biosensing

Metamaterials-Based Label-Free Nanosensor for Conformation and Affinity Biosensing

Plasmonic and Photothermal Immunoassay Via Enzyme-Triggered Crystal Growth on Gold Nanostars

Toward Plasmonic Biosensors Functionalized by A Photoinduced Surface Reaction

A Au nanoparticle and polydopamine co-modified biosensor: A strategy for <i>in situ</i> and label-free surface plasmon resonance immunoassays

Engineering Raspberry-like Plasmonic Nanoclusters as Tags in Surface-Enhanced Raman Scattering-Based Immunoassays

A Au nanoparticle and polydopamine co-modified biosensor: A strategy for in situ and label-free surface plasmon resonance immunoassays

A Combined Plasmonic and Electrochemical Aptasensor Based on Gold Nanopit Arrays for the Detection of Human Serum Albumin

Label-free biosensing with singular-phase-enhanced lateral position shift based on atomically thin plasmonic nanomaterials

Localized Surface Plasmon Resonance (lspr) of Polyelectrolyte-Functionalized Gold-Nanoparticles for Bio-Sensing

Rapid and Sensitive Biomarker Detection Using Molecular Imprinting Polymer Hydrogel and Surface-Enhanced Raman Scattering

Plasmonic metal nanoparticles as efficient mass tags for ion signal amplification and ultrasensitive detection of protein markers

Analysis of immunoreaction with localized surface plasmon resonance biosensor.

Ultrahigh‐Sensitivity Sandwiched Plasmon Ruler for Label‐Free Clinical Diagnosis

MASS-producible low-cost AU nanostructure nanoplasmonic biosensor on optofluidic-portable platform

Liquid-metal-based microfluidic nanoplasmonic platform for point-of-care naked-eye antibody detection